Trials / Active Not Recruiting
Active Not RecruitingNCT04229160
Noninvasive 3D Mapping in Persistent Atrial Fibrillation, to Describe Modifications of the Arrhythmogenic Substrate After Pulmonary Vein Isolation and Identify Potential Predicting Factors of Ablation Success
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Atrial fibrillation (AF) is the most common cardiac arrhythmia in adults. It is a major cause of ischemic stroke and heart failure. Intravascular cardiac ablation of the left atrium by catheter delivery is an efficient treatment to restore sinus rhythm. AF ablation is a class IIa treatment for patients with symptomatic persistent AF refractory or intolerant to antiarrhythmic medication. There are still many debates considering the ablation strategy. The pulmonary veins remain the cornerstone of AF ablation therapy, even in persistent AF. There is a large electrical remodeling occurring in the left atrium between paroxysmal AF, early persistent AF and long-standing persistent AF. However, no multicentric and randomized study has demonstrated so far the interest of targeting other left atrial substrate, such as rotors or focal sources. Our study aims to describe with a noninvasive mapping system the arrhythmogenic substrate of persistent AF \> 6 months pre- and post-cardioversion, and after pulmonary vein isolation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Noninvasive mapping (Cardioinsight® system) | Noninvasive mapping (Cardioinsight® system) of the left atria before the Atrial fibrilation ablation procedure |
| DEVICE | long-term cardiac monitoring (LINQ system) | long-term cardiac monitoring (LINQ system) is used to evaluate recurrence rate following AF ablation procedure |
| PROCEDURE | Atrial Fibrillation ablation procedure | Atrial Fibrillation ablation procedure is done with standard practice |
Timeline
- Start date
- 2020-06-09
- Primary completion
- 2025-06-24
- Completion
- 2026-06-24
- First posted
- 2020-01-18
- Last updated
- 2025-09-17
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04229160. Inclusion in this directory is not an endorsement.